Personalized Medicine
321 articles
A Year in Review: 2022 in Research
What progress was made in pancreatic treatment and screening? Learn about the major pancreatic cancer developments of 2022.
Clinical Trial For OncoTreat Being Developed
Researcher Kenneth Olive is developing OncoTreat, a method matches a patient’s tumor to the most effective drugs for their pancreatic cancer.
Study Reveals Molecular Differences in Young-Onset Pancreatic Cancer
There has been a notable increase in cases of young onset pancreatic cancer. Dr. Jashodeep Datta and team are exploring why this is happening.
A Year in Review: 2020
In March 2020, life as we knew it changed. The way we work, the way we gather, the way we each live our daily lives all felt upended, seemingly overnight. The global pandemic of COVID-19 affected everything, including cancer care and research. COVID-19 brought new risks to cancer patients, whose immune systems are compromised from […]
Tumor Biology Matters
Dr. Lynn Matrisian of PanCAN, explains that molecular profiling of a pancreatic cancer patient’s tumor can show which treatment will work best.
Tumor Subtypes Potentially Provide Clues About Prognosis and Treatment
Drs. Andrew Aguirre and David Ting are teasing out the differences between pancreatic cancer subtypes, to get treatments that work better.
Pancreatic Cancer Research Highlights from ASCO GI 2025
Read about the pancreatic cancer research highlights from the ASCO GI 2025 conference, where treatments and quality-of-life were discussed.
Pancreatic Cancer: 2018 Highlights And Looking Forward to 2019
Dr. Allyson Ocean leads an overview of the new treatments and protocol from 2018 as well as what are the next steps in treatment for 2019.
Fighting Pancreatic Cancer in a Petri Dish
Dr. David Tuveson is growing pancreatic cancer tissue called organoids in the lab, to test which drugs will be most effective against a patient’s tumor.
Personalized Immunotherapy Vaccine for Pancreatic Cancer
Researchers are creating a personalized vaccine to stimulate a pancreatic cancer patient’s immune system after surgery and chemotherapy.
Precision Promise Places Patients at Center of Research
Dr. Diane Simeone explains the different approach to pancreatic cancer clinical trials taken by the Precision Promise program.
CRISPR: A New Tool to Help Understand Cancer-Linked Mutations
Lukas Dow, Ph.D., is using CRISPR technology to find better ways to fight cancer by editing the genome.